TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules - Concepedia

Concepedia

Publication | Closed Access

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules

113

Citations

34

References

2012

Year

Qian Liu, Jessica D. Sun, Jingli Wang, Dharmendra Ahluwalia, Amanda F. Baker, Lee D. Cranmer, Damien Ferraro, Yan Wang, Jian-Xin Duan, W. S. Ammons,

Cancer Chemotherapy and Pharmacology

Translational MedicineHypoxia (Medicine)PharmacologyHypoxia-activated ProdrugClinical PharmacologyPharmacotherapyMedicineDrug DiscoveryOxidative Stress

References

	Year	Citations

Page 1

Page 1